Minerva Neurosciences, Inc. Share Price & Technical Analysis
NERV · $5.26 (-0.75%)
Healthcare / Biotechnology
$5.26
-0.75%
Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone, which is in Phase 3 confirmatory trial for the treatment of negative symptoms in patients with schizophrenia. Minerva Neurosciences, Inc. was incorporated in …
Price chart
Seasonality
May has 2 positive and 3 negative years (last 5 years shown)
-18% return in May, 30% avg return in past 3 year May month.
45% return in 2026, 91% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 3% | 61% | -6% | 7% | -18% | – | – | – | – | – | – | – | 45% |
| 25 | 5% | -26% | 0% | 0% | -12% | 6% | 12% | 26% | -9% | 100% | 0% | -2% | 100% |
| 24 | 35% | -68% | -4% | -8% | 9% | 23% | -6% | -10% | -4% | -11% | -4% | -4% | -52% |
| 23 | 50% | -8% | -24% | 75% | 94% | 52% | 8% | -9% | -18% | -31% | 59% | -22% | 225% |
| 22 | 0% | -15% | 18% | -40% | -22% | 0% | -23% | 319% | -13% | -71% | 30% | -54% | 128% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Emerging · Neutral
Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone, which is in Phase 3 confirmatory trial for the treatment of negative symptoms in patients with schizophrenia. Minerva Neurosciences, Inc. was incorporated in 2007 and is based in Burlington, Massachusetts.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$261.83M
P/E ratio
—
52W high
$12.46
52W low
$1.35
Volume
84,013
Beta
-0.10
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Minerva Neurosciences, Inc. share price today?
- Minerva Neurosciences, Inc. (NERV) last traded around $5.26 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does NERV have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for NERV. Download the app for real-time alerts.
- How can I analyze Minerva Neurosciences, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.